Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy

References

• Huntly BJP, Gilliland DG. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer. 2005;5(4):311–321.
   PubMed Web of Science ®Google Scholar
• Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367(6464):645–648.
   PubMed Web of Science ®Google Scholar
• Corces-Zimmerman MR, Hong WJ, Weissman IL, et al. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci USA. 2014;111(7):2548–2553.
   PubMed Web of Science ®Google Scholar
• Jan M, Snyder TM, Corces-Zimmerman MR, et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med. 2012;4(149):149ra118.
   PubMed Web of Science ®Google Scholar
• Kiel MJ, Yilmaz OH, Iwashita T, et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121(7):1109–1121.
   PubMed Web of Science ®Google Scholar
• Xie Y, Yin T, Wiegraebe W, et al. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature. 2009;457(7225):97–101.
   PubMed Web of Science ®Google Scholar
• Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829–834.
   PubMed Web of Science ®Google Scholar
• Kunisaki Y, Bruns I, Scheiermann C, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502(7473):637–643.
   PubMed Web of Science ®Google Scholar
• Greenbaum A, Hsu YM, Day RB, et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature. 2013;495(7440):227–230.
   PubMed Web of Science ®Google Scholar
• Acar M, Kocherlakota KS, Murphy MM, et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature. 2015;526(7571):126–130.
   PubMed Web of Science ®Google Scholar
• Chen JY, Miyanishi M, Wang SK, et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche. Nature. 2016;530(7589):223–227.
   PubMed Web of Science ®Google Scholar
• Guezguez B, Campbell CJV, Boyd AL, et al. Regional localization within the bone marrow influences the functional capacity of human HSCs. Cell Stem Cell. 2013;13(2):175–189.
   PubMed Web of Science ®Google Scholar
• Watchman CJ, Bourke VA, Lyon JR, et al. Spatial distribution of blood vessels and CD34+ hematopoietic stem and progenitor cells within the marrow cavities of human cancellous bone. J Nucl Med. 2007;48(4):645–654.
   PubMed Web of Science ®Google Scholar
• Patel SA, Meyer JR, Greco SJ, et al. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol. 2010;184(10):5885–5894.
   PubMed Web of Science ®Google Scholar
• Saffrich R, Seckinger A, Krause U, et al. Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism . Stem Cells. 2007;25(3):798–806.
   PubMed Web of Science ®Google Scholar
• Corselli M, Chin CJ, Parekh C, et al. Perivascular support of human hematopoietic stem/progenitor cells. Blood. 2013;121(15):2891–2901.
   PubMed Web of Science ®Google Scholar
• Pinho S, Lacombe J, Hanoun M, et al. PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J Exp Med. 2013;210(7):1351–1367.
   PubMed Web of Science ®Google Scholar
• Salati S, Lisignoli G, Manferdini C, et al. Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage. PLOS One. 2013;8(1):e53496.
   PubMed Web of Science ®Google Scholar
• Shiozawa Y, Takenouchi H, Taguchi T, et al. Human osteoblasts support hematopoietic cell development in vitro. Acta Haematol. 2008;120(3):134–145.
   PubMed Web of Science ®Google Scholar
• Boyd AL, Campbell CJV, Hopkins CI, et al. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs. J Exp Med. 2014;211(10):1925–1935.
   PubMed Web of Science ®Google Scholar
• Le Y, Fraineau S, Chandran P, et al. Adipogenic mesenchymal stromal cells from bone marrow and their hematopoietic supportive role: towards understanding the permissive marrow microenvironment in acute myeloid leukemia. Stem Cell Rev Rep. 2016;12(2):235–244.
   PubMed Web of Science ®Google Scholar
• Moschoi R, Imbert V, Nebout M, et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood. 2016;128(2):253–264.
   PubMed Web of Science ®Google Scholar
• Vanegas NDP, Vernot JP. Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche. Exp Hematol Oncol. 2017;6:2.
   PubMedGoogle Scholar
• Wu L, Amarachintha S, Xu J, et al. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity. Br J Haematol. 2018;183(3):445–456.
   PubMed Web of Science ®Google Scholar
• Hu K, Gu Y, Lou L, et al. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via wnt/β-catenin signaling pathway. J Hematol Oncol. 2015;8:1.
   PubMed Web of Science ®Google Scholar
• Boyd AL, Salci KR, Shapovalova Z, et al. Nonhematopoietic cells represent a more rational target of in vivo hedgehog signaling affecting normal or acute myeloid leukemia progenitors. Exp Hematol. 2013;41(10):858–869.
   PubMed Web of Science ®Google Scholar
• Boyd AL, Reid JC, Salci KR, et al. Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche. Nat Cell Biol. 2017;19(11):1336–1347.
   PubMed Web of Science ®Google Scholar
• De Toni F, Racaud-Sultan C, Chicanne G, et al. A crosstalk between the wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene. 2006;25(22):3113–3122.
   PubMed Web of Science ®Google Scholar
• Chaudhry P, Yang X, Wagner M, et al. Retinoid-regulated FGF8f secretion by osteoblasts bypasses retinoid stimuli to mediate granulocytic differentiation of myeloid leukemia cells. Mol Cancer Ther. 2012;11(2):267–276.
   PubMed Web of Science ®Google Scholar
• Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007;28(7):299–307.
   PubMed Web of Science ®Google Scholar
• Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10(4):463–471.
   PubMed Web of Science ®Google Scholar
• Uy GL, Rettig MP, Motabi IH, et al. A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood. 2012;119(17):3917–3924.
   PubMed Web of Science ®Google Scholar
• Habringer S, Lapa C, Herhaus P, et al. Dual targeting of acute leukemia and supporting niche by CXCR4-directed theranostics. Theranostics. 2018;8(2):369–383.
   PubMed Web of Science ®Google Scholar
• Potocnik AJ, Brakebusch C, Fässler R. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity. 2000;12(6):653–663.
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T, Craddock C, Nakamoto B, et al. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA. 1995;92(21):9647–9651.
   PubMed Web of Science ®Google Scholar
• Jacamo R, Chen Y, Wang Z, et al. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance . Blood. 2014;123(17):2691–2702.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Takemoto N, Sato T, et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med. 2003;9(9):1158–1165.
   PubMed Web of Science ®Google Scholar
• Leone DR, Giza K, Gill A, et al. An assessment of the mechanistic differences between two integrin α4β1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther. 2003;305(3):1150–1162.
   PubMed Web of Science ®Google Scholar
• Ramirez P, Rettig MP, Uy GL, et al. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood. 2009;114(7):1340–1343.
   PubMed Web of Science ®Google Scholar
• Feral CC, Nishiya N, Fenczik CA, et al. CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci U S A. 2005;102(2):355–360.
   PubMed Web of Science ®Google Scholar
• Cantor J, Slepak M, Ege N, et al. Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity. J Immunol. 2011;187(2):851–860.
   PubMed Web of Science ®Google Scholar
• Bajaj J, Konuma T, Lytle NK, et al. CD98-mediated adhesive signaling enables the establishment and propagation of acute myelogenous leukemia. Cancer Cell. 2016;30(5):792–805.
   PubMed Web of Science ®Google Scholar
• Hayes GM, Chinn L, Cantor JM, et al. Antitumor activity of an anti-CD98 antibody. Int J Cancer. 2015;137(3):710–720.
   PubMed Web of Science ®Google Scholar
• Schweitzer KM, Dräger AM, van der Valk P, et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol. 1996;148(1):165–175.
   PubMed Web of Science ®Google Scholar
• Sackstein R, Dimitroff CJ. A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity. Blood. 2000;96(8):2765–2774.
   PubMed Web of Science ®Google Scholar
• Dimitroff CJ, Lee JY, Rafii S, et al. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol. 2001;153(6):1277–1286.
   PubMed Web of Science ®Google Scholar
• Chien S, Zhao X, Brown M, et al. A novel small molecule E-selectin inhibitor GMI-1271 blocks adhesion of AML blasts to E-selectin and mobilizes blood cells in nodscid IL2Rgc−/− mice engrafted with human AML. Blood. 2012;120(21):4092.
   Web of Science ®Google Scholar
• Barbier V, Erbani J, Fiveash C, et al. Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance. Nat Commun. 2020;11(1):2042.
   PubMed Web of Science ®Google Scholar
• DeAngelo DJ, Jonas BA, Liesveld JL, et al. Uproleselan (GMI-1271), an E-selectin antagonist, improves the efficacy and safety of chemotherapy in relapsed/refractory (R/R) and newly diagnosed older patients with acute myeloid leukemia: final, correlative, and subgroup analyses. Blood. 2018;132(Supplement 1):331–331.
   Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249–257.
   PubMed Web of Science ®Google Scholar
• Keith B, Simon MC. Hypoxia-inducible factors. Stem Cells Cancer Cell. 2007;129(3):465–472.
   Google Scholar
• Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93(4):266–276.
   PubMedGoogle Scholar
• Hudson CC, Liu M, Chiang GG, et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol. 2002;22(20):7004–7014.
   PubMed Web of Science ®Google Scholar
• Kong D, Park EJ, Stephen AG, et al. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res. 2005;65(19):9047–9055.
   PubMed Web of Science ®Google Scholar
• Kampen KR, Ter Elst A, de Bont ES. Vascular endothelial growth factor signaling in acute myeloid leukemia. Cell Mol Life Sci. 2013;70(8):1307–1317.
   PubMed Web of Science ®Google Scholar